According to a new study by Harvard researchers, the vast majority of yohimbe sold as a dietary supplement by mainstream retailers in the United States is mislabeled in a way that could pose a safety risk to consumers. Pieter Cohen, assistant professor of medicine at Cambridge Health Alliance, is lead author of the study.
Trending News
Search for Babesiosis Treatment Gets a New Map
New clues to help fight tick-borne disease
Can an AI ‘Co-Scientist’ Accelerate Cancer Research?
Nearly $7 million funds agentic AI tools to assist investigations into cancer’s most pressing…
First Large-Scale Study Shows How Doctors Use AI in Medicine
Which practitioners use artificial intelligence in the clinic, and what do they ask?